Asensus Surgical
ASXC
#8961
Rank
C$0.13 B
Marketcap
$0.50
Share price
0.64%
Change (1 day)
28.29%
Change (1 year)
Categories

P/E ratio for Asensus Surgical (ASXC)

P/E ratio as of December 2024 (TTM): -1.02

According to Asensus Surgical's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.02324. At the end of 2022 the company had a P/E ratio of -1.08.

P/E ratio history for Asensus Surgical from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-1.08-72.64%
2021-3.96623.09%
2020-0.5482228.2%
2019-0.1670-97.75%
2018-7.42-71.59%
2017-26.162.38%
2016-16.1-70.55%
2015-54.6-7.55%
2014-59.1432.4%
2013-11.1470.65%
2012-1.95-94.76%
2011-37.1-26.05%
2010-50.2-53.64%
2009-108108.33%
2008-52.0-79.13%
2007-24933.3%
2006-187-52.07%
2005-390620%
2004-54.2137.27%
2003-22.8508.27%
2002-3.75-103.53%
2001106

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
< -1000 109,668.97%๐Ÿ‡บ๐Ÿ‡ธ USA
56.9-5,660.44%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.